These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30530636)

  • 1. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
    Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
    J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
    Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Novel Alleles and Genotype/Phenotype Correlations Resulting from the Analysis of 108 Previously Undetected Mutations in Patients Affected by Neurofibromatosis Type I.
    Bonatti F; Adorni A; Matichecchia A; Mozzoni P; Uliana V; Pisani F; Garavelli L; Graziano C; Gnoli M; Carli D; Bigoni S; Boschi E; Martorana D; Percesepe A
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28961165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer.
    Campos B; Balmaña J; Gardenyes J; Valenzuela I; Abad O; Fàbregas P; Volpini V; Díez O
    Breast Cancer Res Treat; 2013 Jun; 139(2):597-602. PubMed ID: 23624750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
    Koczkowska M; Chen Y; Callens T; Gomes A; Sharp A; Johnson S; Hsiao MC; Chen Z; Balasubramanian M; Barnett CP; Becker TA; Ben-Shachar S; Bertola DR; Blakeley JO; Burkitt-Wright EMM; Callaway A; Crenshaw M; Cunha KS; Cunningham M; D'Agostino MD; Dahan K; De Luca A; Destrée A; Dhamija R; Eoli M; Evans DGR; Galvin-Parton P; George-Abraham JK; Gripp KW; Guevara-Campos J; Hanchard NA; Hernández-Chico C; Immken L; Janssens S; Jones KJ; Keena BA; Kochhar A; Liebelt J; Martir-Negron A; Mahoney MJ; Maystadt I; McDougall C; McEntagart M; Mendelsohn N; Miller DT; Mortier G; Morton J; Pappas J; Plotkin SR; Pond D; Rosenbaum K; Rubin K; Russell L; Rutledge LS; Saletti V; Schonberg R; Schreiber A; Seidel M; Siqveland E; Stockton DW; Trevisson E; Ullrich NJ; Upadhyaya M; van Minkelen R; Verhelst H; Wallace MR; Yap YS; Zackai E; Zonana J; Zurcher V; Claes K; Martin Y; Korf BR; Legius E; Messiaen LM
    Am J Hum Genet; 2018 Jan; 102(1):69-87. PubMed ID: 29290338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I.
    Riva M; Martorana D; Uliana V; Caleffi E; Boschi E; Garavelli L; Ponti G; Sangiorgi L; Graziano C; Bigoni S; Rocchetti LM; Madeo S; Soli F; Grosso E; Carli D; Goldoni M; Pisani F; Percesepe A
    Genes Chromosomes Cancer; 2022 Jan; 61(1):10-21. PubMed ID: 34427956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
    Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
    Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.
    Pasmant E; Sabbagh A; Spurlock G; Laurendeau I; Grillo E; Hamel MJ; Martin L; Barbarot S; Leheup B; Rodriguez D; Lacombe D; Dollfus H; Pasquier L; Isidor B; Ferkal S; Soulier J; Sanson M; Dieux-Coeslier A; Bièche I; Parfait B; Vidaud M; Wolkenstein P; Upadhyaya M; Vidaud D;
    Hum Mutat; 2010 Jun; 31(6):E1506-18. PubMed ID: 20513137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline and Somatic
    Wang X; Kallionpää RA; Gonzales PR; Chitale DA; Tousignant RN; Crowley JP; Chen Z; Yoder SJ; Blakeley JO; Acosta MT; Korf BR; Messiaen LM; Tainsky MA
    Cancer Prev Res (Phila); 2018 Oct; 11(10):655-664. PubMed ID: 30104415
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
    Wang X; Teer JK; Tousignant RN; Levin AM; Boulware D; Chitale DA; Shaw BM; Chen Z; Zhang Y; Blakeley JO; Acosta MT; Messiaen LM; Korf BR; Tainsky MA
    Genes Chromosomes Cancer; 2018 Jan; 57(1):19-27. PubMed ID: 28891274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
    Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
    BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
    Yap YS; Munusamy P; Lim C; Chan CHT; Prawira A; Loke SY; Lim SH; Ong KW; Yong WS; Ng SBH; Tan IBH; Callen DF; Lim JCT; Thike AA; Tan PH; Lee ASG
    Breast Cancer Res Treat; 2018 Oct; 171(3):719-735. PubMed ID: 29926297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.
    Güran S; Safali M
    Cancer Genet Cytogenet; 2005 Jan; 156(1):86-8. PubMed ID: 15588864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1.
    Rasmussen SA; Colman SD; Ho VT; Abernathy CR; Arn PH; Weiss L; Schwartz C; Saul RA; Wallace MR
    J Med Genet; 1998 Jun; 35(6):468-71. PubMed ID: 9643287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors.
    Kluwe L; Friedrich RE; Peiper M; Friedman J; Mautner VF
    Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NF1 somatic mutational landscape in sporadic human cancers.
    Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
    Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1.
    Courtney E; Chan SH; Li ST; Ishak D; Merchant K; Shaw T; Chay WY; Chin FHX; Wong WL; Wong A; Ngeow J
    Fam Cancer; 2020 Oct; 19(4):353-358. PubMed ID: 32405727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.
    Kang E; Kim YM; Seo GH; Oh A; Yoon HM; Ra YS; Kim EK; Kim H; Heo SH; Kim GH; Osborn MJ; Tolar J; Yoo HW; Lee BH
    J Hum Genet; 2020 Jan; 65(2):79-89. PubMed ID: 31776437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
    Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
    PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.